New CRISPR approach targets gene fusions found in 1 in 5 cancers

AI Summary

Scientists at Peter Mac have developed a CRISPR method designed to target gene fusions found in a substantial share of cancers. The approach could enable treatments that recognize the distinctive molecular signature created by fused genes.

Peter Mac scientists have developed a way to precisely target the "unique molecular fingerprint" created when two genes become abnormally fused together, a discovery that could lead to a new way to treat a wide array of cancers.